Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the anaphylaxis treatment market?

The market for anaphylaxis treatment has expanded significantly over the past few years. From measuring $6.19 billion in 2024, it is expected to rise to $6.61 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. The historical growth can be credited to an increased prevalence of allergic reactions, greater acknowledgment of anaphylaxis, improved access to epinephrine auto-injectors, heightened public knowledge and education, along with enhanced training for healthcare professionals.

What will be the anaphylaxis treatment market size in the future?

In the upcoming years, the market size for anaphylaxis treatment is anticipated to experience significant growth, swelling to a value of $8.72 billion by 2029, this is projected to happen at a compound annual growth rate (CAGR) of 7.2%. This increase over the forecast period can be traced back to advancements in biologic therapies, personalized treatment strategies, worldwide initiatives for food safety, patient involvement and representation, and more efficient emergency medical services. Key trends during the forecast period will be innovations in auto-injectors, the use of telemedicine for managing anaphylaxis, better allergen immunotherapy, the emergence of biometric wearables for allergen detection, and cooperative efforts in allergy research.

Get your anaphylaxis treatment market report here!

https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report

What main drivers are fueling expansion in the anaphylaxis treatment market?

The growth of the anaphylaxis treatment market is anticipated to be propelled by the increasing incidence of food allergies. An immune reaction to proteins in food is known as a food allergy. Anaphylaxis treatment is crucial in halting the potentially fatal progression of allergic symptoms that include skin manifestations, mucosal surface reactions, respiratory issues, hypotension, and end-organ dysfunction. As an example, the Centers for Disease Control and Prevention, an agency of the US government, reported in January 2023 that in 2021, 31.8% of adults aged 18 and over reported having either eczema, a seasonal allergy, or a food allergy. A quarter (25.7%) of these adults suffered from a seasonal allergy, 6.2% from a food allergy, and 7.3% from eczema. Moreover, the Food Standards Agency, a non-ministerial department in the UK, shared in August 2024 that between October 2021 and August 27, 2023, a total of 296 valid case reports were submitted to their registry, likely representing less than 5% of accidental reactions in the UK. It was found that 72%, or 213 of these reports, were due to food triggers, and 97.7%, or 208, occurred in children and young people aged 18 or below. Only 28 clinics and 11 Accident & Emergency (A&E) departments had registered for access to the platform. Consequently, the increasing incidence of food allergies is fueling the expansion of the anaphylaxis treatment market.

What key areas define the segmentation of the global anaphylaxis treatment market?

The anaphylaxis treatment market covered in this report is segmented –

1) By Treatment: Epinephrine, Antihistamines, Steroids, Beta-antagonists, Other Treatments

2) By Product: Tablets, Capsules, Other Products

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

4) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-Injectors, Vials Or Syringes

2) By Antihistamines: Oral Antihistamines, Injectable Antihistamines

3) By Steroids: Oral Steroids, Injectable Steroids

4) By Beta-antagonists: Oral Beta-blockers, Injectable Beta-blockers

5) By Other Treatments: Corticosteroids, Intravenous Fluids, Other Supportive Treatments

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp

Who are the dominant players expanding their reach in the anaphylaxis treatment market?

Major companies operating in the anaphylaxis treatment market include Merck & Co. Inc., Novartis International AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies, Sun Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abelló A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., Meridian Medical Technologies LLC, Aquestive Therapeutics Inc., Sandoz Inc., Adamis Pharmaceutical Corporation, Impax Laboratories LLC

How are evolving market trends shaping anaphylaxis treatment Strategies?

Innovations in product development is a noticeable trend emerging in the market for anaphylaxis treatment. Major firms in this marketplace are progressing their products in order to maintain market dominance. For example, in April 2022, Aquestive Therapeutics Inc., a pharmaceutical company based in the US, was awarded the Fast Track designation for its product AQST-109, meant for treating severe allergic reactions, including anaphylaxis, by the Food and Drug Administration. The company is proceeding with the clinical trials of AQST-109, the first of its kind oral epinephrine product candidate. It has shown similar clinical outcomes to autoinjectors (like EpiPen and Auvi-Q) for managing allergic crises, including anaphylaxis.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12105

Which regions are emerging as leaders in the anaphylaxis treatment market?

North America was the largest region in the anaphylaxis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anaphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Phosphate Fertilizer Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/phosphate-fertilizer-global-market-report

Food Acidulants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/food-acidulants-global-market-report

Hyperphosphatemia Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hyperphosphatemia-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: